To establish immunotherapy or vaccination against tumor immunogenic antigens and eventually prolonged survival of patients, expression of these antigens should first be examined in a well-characterized series of cancer tissue specimens, which this experiment currently carried out for MAGE-A6 and MAGE-11 expressions in BC. Here, MAGEA11 is linked to breast cancer.